Bevacizumab vs Dacarbazine in Metastatic Melanoma
Clinical trial NCT01705392 · TERMINATED
Trial details
- NCT number
- NCT01705392
- Sponsor
- Haukeland University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2017-02-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.